Chemotherapy Induced Anemia Market is driven by rising cancer incidence
The Chemotherapy Induced Anemia Market includes erythropoiesis-stimulating agents (ESAs) such as epoetin alfa, darbepoetin alfa, biosimilars, intravenous iron therapies, and blood transfusion services. These therapies mitigate the adverse effects of chemotherapy-induced hemoglobin reduction by stimulating red blood cell production, improving oxygen delivery, and reducing the need for repeated...
0 Commentarios 1 Acciones 97 Views 0 Vista previa